0001012975-19-000254.txt : 20190401 0001012975-19-000254.hdr.sgml : 20190401 20190401173514 ACCESSION NUMBER: 0001012975-19-000254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190401 DATE AS OF CHANGE: 20190401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOODMAN COREY S CENTRAL INDEX KEY: 0001278411 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38841 FILM NUMBER: 19722047 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adelman Robert J CENTRAL INDEX KEY: 0001329161 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38841 FILM NUMBER: 19722048 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: venBio Global Strategic GP, Ltd. CENTRAL INDEX KEY: 0001770835 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38841 FILM NUMBER: 19722049 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-800-0800 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: venBio Global Strategic GP, L.P. CENTRAL INDEX KEY: 0001770834 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38841 FILM NUMBER: 19722050 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-800-0800 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: venBio Global Strategic Fund, L.P. CENTRAL INDEX KEY: 0001504130 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38841 FILM NUMBER: 19722051 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-522-0100 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC CENTRAL INDEX KEY: 0001357874 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 302 EAST PETTIGREW STREET STREET 2: SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-314-5512 MAIL ADDRESS: STREET 1: 302 EAST PETTIGREW STREET STREET 2: SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-04-01 1 0001357874 PRECISION BIOSCIENCES INC DTIL 0001504130 venBio Global Strategic Fund, L.P. C/O VENBIO PARTNERS, LLC 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 1 0 1 0 0001770834 venBio Global Strategic GP, L.P. C/O VENBIO PARTNERS, LLC 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 0 0 1 0 0001770835 venBio Global Strategic GP, Ltd. C/O VENBIO PARTNERS, LLC 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 0 0 1 0 0001329161 Adelman Robert J C/O VENBIO PARTNERS, LLC 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 1 0 1 0 0001278411 GOODMAN COREY S C/O VENBIO PARTNERS, LLC 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 0 0 1 0 Common Stock 2019-04-01 4 P 0 50000 16.00 A 50000 I See footnote Common Stock 2019-04-01 4 C 0 3747623 A 3797623 I See footnote Common Stock 2019-04-01 4 C 0 467518 A 4265141 I See footnote Series A Preferred Stock 2019-04-01 4 C 0 8000000 0 D Common Stock 3747623 0 I See footnote Series B Preferred Stock 2019-04-01 4 C 0 998004 0 D Common Stock 467518 0 I See footnote Each share of the Issuer's preferred stock converted into shares of the Issuer's common stock, $0.000005 par value per share, on a one-for-2.134686 basis upon the closing of the Issuer's initial public offering, after giving effect to the reverse stock split effected by the Issuer in connection with the initial public offering. venBio Global Strategic GP, LP is the sole general partner of venBio Global Strategic Fund, LP and venBio Global Strategic GP, Ltd. is the sole general partner of venBio Global Strategic GP, L.P. Robert Adelman and Corey Goodman are directors of venBio Global Strategic GP, Ltd. Each of venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd., Mr. Adelman and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein. venBio Global Strategic Fund, LP, by: venBio Global Strategic GP, LP, its general partner, by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ Dave Pezeshki, Attorney-in-Fact 2019-04-01 venBio Global Strategic GP, LP, its general partner, by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ Dave Pezeshki, Attorney-in-Fact 2019-04-01 venBio Global Strategic GP, Ltd., its general partner, by: /s/ Dave Pezeshki, Attorney-in-Fact 2019-04-01 Robert Adelman, by: /s/ Dave Pezeshki, Attorney-in-Fact 2019-04-01 Corey Goodman, by: /s/ Dave Pezeshki, Attorney-in-Fact 2019-04-01